One of our founders, Dr. Thomas Lei was recently invited to give a talk at Regional Medical Center of San Jose, entitled:
New Era-Lung Cancer Diagnosis, Staging And Treatment From Electromagnetic Navigation Bronchoscopy (ENB), Endobronchospic Ultrasound (EBUS), To Robotic Assisted Navigation Bronchoscopy (RANB), Tool In Lesion (TIL) Confirmation With Cone Beam CT Or Advanced Fluoroscopy 20 years Journey to Perfection
On August 7, 2021, our representative joined the1st Annual Thoracic Oncology Program (TOP) Executive Summit hosted by Intuitive in San Diego.
At the TOP summit, national stakeholders: C-level administrators, Executive Physician Leaders, Program Directors, and Oncology Program coordinators came together sharing how they found success in collaboration, strategic and tactical alignment, data analytics, best practices, and Intuitive ecosystem resources available to their individual programs.
https://web.cvent.com/event/baca2eca-9c10-4443-ae03-90f1213706fd/summary
We are excited to announce that Zeus Medical will support and join leading pulmonologists, interventional pulmonologists and thoracic surgeons around world to participate in the 14Th ANNUAL GLOBAL LUNG HEALTH SUMMIT & SAB WINTER CME EVENT February 14-15th, 2020 Phoenix, Arizona!
Our patented technology, BETLA TM and ip-tubeTM will be showcased at this event . No matter which navigation bronchoscopy platform you use, BETLA TM and ip-tubeTM would be great addition to streamline and make your interventional pulmonary procedure more robust.
We are entering in a new era of diagnosis and treatment of lung cancer. Please join colleagues from around the world for two days of lung cancer innovation, education and partnership, together, we can continue to improve survival and cultivate hope for lung cancer patients.
14Th ANNUAL GLOBAL LUNG HEALTH SUMMIT & SAB WINTER CME EVENT
February 14-15th, 2020 Phoenix, Arizona
Chinese regulatory authority recently granted clearance for our proprietary BETLA adapter system. Soon it will be available to interventional pulmonologists and thoracic surgeons all over China, who are the pioneers in early lung cancer diagnosis and treatment through the novel, minimum invasive approach, such as navigation bronchoscopy, microwave ablation therapy, all to make the diagnosis and treatment in one session. Undoubtedly, BETLA adapter system, will play an important role in maintaining the stability of bronchoscope and related tools, during IP procedures, will improve accuracy and precision.
March 4th, 2019, a team of pioneer physicians lead by world renown thoracic surgeons, Dr. Calvin Ng and Dr. Rainbow Lau, from the Faculty of Medicine of The Chinese University of Hong Kong (CUHK), successfully performed the first ever cases in Asian Pacific region, using combined electromagnetic navigation bronchoscopy (ENB) and Cone beam CT technology in diagnosis and treatment of inoperable lung cancer, with Bronchoscopic Microwave Ablation (BMA) in a hybrid operating room. These combined novel technologies allow physicians achieving towards near 100% precision and accuracy in the lung cancer diagnosis and treatment through targeted delivery of a BMA probe into the different part of the tumor, directly destroying the cancer tissue in a minimal invasive approach. This revolutionary breakthrough opens a brand new era of lung cancer diagnosis and treatment, gives hopes to those patients who are deemed to be inoperable with conventional lung surgery or radiation therapy with minimal morbidity. Zeus Medical was there witnessing and participating in this exciting milestone event, with its proprietary BETLA adapter system and ip-tube.
For more information, please visit the following links:
This video link clearly shows BETLA adapter system being used to secure the bronchoscope during navigation, diagnosis and cancer ablation during cone beam CT scanning.
https://www.youtube.com/watch?time_continue=11&v=Jk32Emj9Th8
The following link contains CUHK news release, Dr. Rainbow Lau’s discussion on Microwave technology, Dr. Clavin Ng explaining advantage and benefits of the BMA approach, video clip of ENB-Cone Beam CT and BMA:
Detailed news release and introduction on BMA approach in diagnosis and treatment of lung cancer:
Zeus Medical released the second generation BETLA , with new soft gel plug and cap membrane ring design features. The new BETLA adapter system achieves better air seal and renders smooth, robust operation.
ip-tubeTM , an specialty oral endotracheal tube is exclusively designed to provide robust operation in interventional pulmonary (IP) procedures, i.e. navigation bronchoscopy, endo bronchoscopy ultrasound, tumor debulking and pulmonary stenting etc. By its unique design, ip-tubeTM provides better tube stability during IP procedures, gives larger inner diameter (ID) working space while maintaining either the same or smaller outer diameter (OD) to accommodate the larger pore bronchoscope usually being used during IP procedures. The forward bevel design of the ip-tubeTM exposes more paratracheal lymph nodes to be biopsied compared to existing endotracheal tube. The two side caeli oculus(Murphy eyes) improves ventilation, reduces airway pressure, resistance during procedures while the tube space is largely taken up by the bronchoscope. The straight up, ergonomic design of proximal portion of ip-tubeTM, facilitates surgeon’s smooth operation without back hurting back from bending forward. The sleek, fit length design eliminates the need of tube cutting as routinely being done with currently available endotracheal tubes.
BETLA Adapter system has been successfully tested and sold across North America. So far, BETLA Adapter system has been adopted and incorporated in interventional bronchoscopy procedures (IP) at many prominent medical centers, such as Johns Hopkins medical center, New York Presbyterian Hospital-Cornell medical center, Kaiser systems in Northern and Southern California and El Camino hospital, interventional pulmonary department. Currently, BETLA Adapter system is only available in US market.
"A Prospective Clinical Study of Tom-Stylet, Its Safety, Efficacy for Intubation, Accuracy in Measuring, Guiding ETT Position" was presented at the 2017 Society for Technology in Anesthesia (STA) Annual Meeting January 11-14, 2017 in San Diego, California. The presentation attracted many meeting attendees, who showed great interest in this novel device its ability to provide instant endotracheal tube tip position in a non-invasive fashion. Tom-Stylet is currently available in US market only.
"A Prospective Clinical Study of Tom-Stylet, Its Safety, Efficacy for Intubation, Accuracy in Measuring, Guiding ETT Position" has been accepted for presentation at the 2017 Society for Technology in Anesthesia (STA) Annual Meeting taking place January 11-14, 2017 in San Diego, California. The single center, prospective clinical trial was sponsored by Zeus Medical .
In April, 2016, a clinical observational study to evaluate the safety and efficacy of the Tom-Stylet was completed at the South-West Hospital, Chongqing, China. 26 cases were enrolled in the study. All patients were successfully intubated endotracheally with Tom-Stylet. 7 of the 26 cases (27%), endotracheal tube (ETT) were placed in good position( 3cm above the carina) based on anesthesiologists’ experience and physical exam: auscultation and symmetric chest wall movement; in one case, the ETT was required to pull back about 1 cm; 18 of the 26 cases (69%), the ETT were required to push down 2.4 cm (mean, 0.5 cm-4 cm) based on Tom-Stylet measurement. In all cases, the ETT positions and mucosa status were confirmed by bronchoscopy, and no mucosa injury was observed in all 26 cases based on pre/post bronchoscopy examination.
We are happy to announce a working relationship with Aleph Films for foreseeable video content!
© 2019 zeus medical | all rights reserved
